Amid a surge in drug-resistant bacteria, researchers believe they have discovered a new class of antibiotics for the first ...
US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 ...
Rigorous testing demonstrates robust antimicrobial performance against bacterial strains relevant to cardiac implanted electronic device (CIED) ...
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
Ph.D., Elutia’s Chief Scientific Officer. “The results demonstrate the robust antimicrobial performance of antibiotic-eluting biologic envelopes in a rigorous model. We believe these new data ...
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results